Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway

Jun-Qing Jin(The Catholic University of Korea Seoul St. Mary's Hospital), Dong‐Jun Lim(The Catholic University of Korea Seoul St. Mary's Hospital)
Endocrinology and Metabolism
October 14, 2021
Cited by 17


Related Papers

No related papers found

Powered by citation graph analysis